Author Correction: Inflammasome signalling in brain function and neurodegenerative disease

Michael T Heneka^{1

2

3}, Róisín M McManus^{4

5}, Eicke Latz^{5

6

7}

Affiliations

¹ Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Bonn, Germany. michael.heneka@ukbonn.de.
² German Center for Neurodegenerative Diseases, Bonn, Germany. michael.heneka@ukbonn.de.
³ Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA. michael.heneka@ukbonn.de.
⁴ Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Bonn, Germany.
⁵ German Center for Neurodegenerative Diseases, Bonn, Germany.
⁶ Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
⁷ Institute of Innate Immunity, University of Bonn, Bonn, Germany.

PMID: 30742056
DOI: 10.1038/s41583-019-0137-1

Published Erratum

Author Correction: Inflammasome signalling in brain function and neurodegenerative disease

Michael T Heneka et al. Nat Rev Neurosci. 2019 Mar.

. 2019 Mar;20(3):187.

doi: 10.1038/s41583-019-0137-1.

Authors

Michael T Heneka^{1

2

3}, Róisín M McManus^{4

5}, Eicke Latz^{5

6

7}

Affiliations

¹ Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Bonn, Germany. michael.heneka@ukbonn.de.
² German Center for Neurodegenerative Diseases, Bonn, Germany. michael.heneka@ukbonn.de.
³ Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA. michael.heneka@ukbonn.de.
⁴ Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Bonn, Germany.
⁵ German Center for Neurodegenerative Diseases, Bonn, Germany.
⁶ Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
⁷ Institute of Innate Immunity, University of Bonn, Bonn, Germany.

PMID: 30742056
DOI: 10.1038/s41583-019-0137-1

Abstract

In the originally published version of this article, the competing interests statement indicated that the authors had no competing interests; however, this statement was incorrect. The statement should have read as follows: 'M.H. receives a consultation fee from IFM Therapeutics, LLC for consultations regarding the pathogenesis and interventional strategies of neurodegenerative disease. E.L. is a scientific co-founder and consultant to IFM Therapeutics. R.M.M. declares no competing interests.' This error has been corrected in the HTML and PDF versions of the article.

PubMed Disclaimer

Erratum for

Inflammasome signalling in brain function and neurodegenerative disease.
Heneka MT, McManus RM, Latz E. Heneka MT, et al. Nat Rev Neurosci. 2018 Oct;19(10):610-621. doi: 10.1038/s41583-018-0055-7. Nat Rev Neurosci. 2018. PMID: 30206330 Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Inflammasome signalling in brain function and neurodegenerative disease

Affiliations

Author Correction: Inflammasome signalling in brain function and neurodegenerative disease

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources